Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Indexes aggregate market data to track performance, provide benchmarks, and simplify investment decisions for portfolios and strategies.
23,902 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
New projections shift the timeline for potential Social Security cuts earlier, prompting retirees and savers to rethi...
Hess Midstream signals a major shift from expansion to cash returns, projecting $850-$900 million in adjusted free ca...
In a hypothetical scenario, Gemini faces a class-action suit after pivoting to prediction markets. Investors wonder i...
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
Geopolitical tensions between the U.S. and Iran are dominating crypto moves, with Bitcoin and XRP trading in tight ra...
Two major AI infrastructure players appear attractively priced as heavy investment in AI chips and automation presses...
As markets remain unsettled in early 2026, retirees seek steady monthly income. A new briefing spotlights five safe, ...
FuboTV’s reverse split failed to spark a lasting rally, with shares sliding as the company reports rising revenue but...
A tiny $1,800 token purchase has triggered a governance attack on Moonwell, risking over $1 million in funds. Analyst...
Century 21 Chief Executive Mike Miedler says recruiting more Latino agents is crucial to serving the majority of futu...
MSFW has fallen sharply since its July 2025 launch, while weekly payouts crater from a peak of $0.97 to a recent $0.1...